<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01424254</url>
  </required_header>
  <id_info>
    <org_study_id>REC#03-025</org_study_id>
    <nct_id>NCT01424254</nct_id>
  </id_info>
  <brief_title>The Effectiveness of Video-capsule Endoscopy in Gastrointestinal Bleeding of Obscure Origin</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Society for Gastrointestinal Endoscopy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American College of Gastroenterology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to compare the cost-effectiveness of VCE to push enteroscopy in
      patients with gastrointestinal bleeding of obscure origin with a negative initial work-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The introduction of the wireless capsule endoscopy (WCE) may dramatically alter
      the management of patients with small bowel disease such as chronic gastrointestinal bleeding
      of obscure origin (CGB). Yet, to date, this non invasive technique has undergone widespread
      diffusion in the absence of properly designed prospective comparative cost-effectiveness
      evaluations.

      Objectives: To examine the clinical impact and cost-effectiveness of a novel approach
      employing WCE compared to that of push enteroscopy (PE).

      Hypothesis: WCE is more cost-effective than PE in patients with CGB. Study design: We propose
      a randomized clinical trial comparing WCE to PE. Study population: Patients with CGB having
      undergone initial normal assessment with gastroscopy, colonoscopy and radiological
      examination of the small bowel.

      Outcomes: Primary objective: To compare the detection rates of &quot;clinically significant&quot; small
      bowel lesions using WCE versus PE in CGB patients randomized to either modality. Secondary
      objectives: To determine the &quot;cure rate&quot; for each technique after 6 months, the
      cost-effectiveness of WCE versus PE, the type of small bowel lesions most likely to impact on
      clinical care, inter-rater variability in reading WCE examinations, the feasibility of WCE
      interpretation by a dedicated technician, the safety of each imaging modality, and to compare
      patient satisfaction and quality of life between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome measure is the detection rate of clinically significant lesions thought to be responsible for the patients with gastrointestinal bleeding of obscure origin</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>resolution of the anemia/recurrent bleeding</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood transfusion requirements</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of required imaging tests (i.e: gastroscopy, colonoscopy, etc)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalization/length of stay</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days away from usual activities (protocol unrelated)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>Following procedure at randomization</time_frame>
    <description>Patient satisfaction questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>Video-Capsule Endoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VCE will be performed in the early morning following 200 mg of simethicone and 250 - 500 mg of erythromycin (as per physician's prescription), ingestion also in the absence of contra-indications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Push Enterosopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Capsule GIVEN IMAGING</intervention_name>
    <description>Injection of Capsule Endoscopy</description>
    <arm_group_label>Video-Capsule Endoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Push-Enteroscopy</intervention_name>
    <description>currently recommended standard</description>
    <arm_group_label>Push Enterosopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  Normal gastroscopy, colonoscopy and small bowel follow through in the last 3 months

        Exclusion Criteria:

          -  Demonstrable source of blood outside the GI tract

          -  Significant cardiopulmonary disease

          -  Suspicion of strictures or fistulae of the GI tract

          -  Pregnancy

          -  Numerous small intestinal diverticula

          -  Zenker's diverticulum

          -  Extensive Crohn's enteritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2011</study_first_submitted>
  <study_first_submitted_qc>August 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2011</study_first_posted>
  <last_update_submitted>August 25, 2011</last_update_submitted>
  <last_update_submitted_qc>August 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>Alan Barkun</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Gastrointestinal Bleeding of Obscure Origin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

